Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial
| Autor: | Geoerger, Birgit *, Kang, Hyoung Jin, Yalon-Oren, Michal, Marshall, Lynley V, Vezina, Catherine, Pappo, Alberto, Laetsch, Theodore W, Petrilli, Antonio S, Ebinger, Martin, Toporski, Jacek, Glade-Bender, Julia, Nicholls, Wayne, Fox, Elizabeth, DuBois, Steven G, Macy, Margaret E, Cohn, Susan L, Pathiraja, Kumudu, Diede, Scott J, Ebbinghaus, Scot, Pinto, Navin |
|---|---|
| Zdroj: | In The Lancet Oncology January 2020 21(1):121-133 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|